Optometry News

Stefano Gandolfi, MD, a glaucoma specialist and Healio | OSN Europe Edition Board Member, died on Sept. 2 at the age of 64 years.

For quite a few years now, we have been hearing the same stats about the prevalence and characteristics of dry eye disease patients in the U.S.

The Early Detection of Vision Impairments for Children Act, if passed, would be the first federal-level program to support state and community approaches for children’s vision and eye health, a major step forward for the eye care community.

CARLSBAD, Calif. — In this Healio Video Perspective from the Women in Ophthalmology Summer Symposium, Tara A. McCannel, MD, PhD, of UCLA Health in Los Angeles explains the health benefits that acupuncture may offer ophthalmologists.

The COVID-19 pandemic had a great impact on the health care system and the well-being of health care professionals, the effects of which are still felt today.

NASHVILLE, Tenn. — A group of forward-thinking optometrists at Optometry’s Meeting shared their criteria for investing in new technology to benefit their patients and their practices.

Prevent Blindness marked September as Sports Eye Safety Month, highlighting data showing that more than 32,600 sports-related eye injuries were treated in the U.S. in 2023, with the highest rate of injury in pool and water sports.

Under a new distribution agreement with Santen SA, Bruder Healthcare will market Eyeleve MGD, the preservative-free ophthalmic emulsion previously sold in the U.S. as Retaine MGD, the company announced in a press release.

CARLSBAD, Calif. — In this Healio Video Perspective from the Women in Ophthalmology Summer Symposium, Lisa M. Nijm, MD, JD, discusses the burden of thyroid eye disease and how it affects quality of life.

The FDA cleared an investigational new drug application for OpCT-001, an investigational cell therapy for the treatment of primary photoreceptor diseases, according to a press release from BlueRock Therapeutics.